Official 2024 U.S. DOL Form 5500 summary for Telix Pharmaceuticals (US) INC (Telix Pharmaceuticals Retirement Plan · EIN 82-4003948 · PN 001): $17.78M net assets, 310 active participants, and $77.29 per $10,000 (77.29 bps).
| Plan Sponsor | Telix Pharmaceuticals (US) INC |
|---|---|
| Filing Identifier | Telix Pharmaceuticals Retirement Plan · EIN 82-4003948 · PN 001 |
| Plan Category & State | 401(k) Defined Contribution (IN) |
| Asset-Size Peer Cohort | $5M-$25M |
| Plan Net Assets (2024) | $17.78M |
| Active Participants | 310 |
| Direct Admin Fee Rate | $77.29 per $10,000 (77.29 bps) |
| Cohort Peer Median | $37.06 per $10,000 (37.06 bps) |
| Primary Recordkeeper / Provider | Fidelity Investments |
| Schedule H Line 4a Remittance | Schedule H Line 4a Late Remittance Reported ($132,711, often administrative timing) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI